Other languages Exicure, Inc.

Equities

Market Closed - Nasdaq Other stock markets 02:00:01 30/04/2024 am IST			5-day change	1st Jan Change
0.5146 ^USD	+2.90%		-4.76%	-11.32%

22/03	North American Morning Briefing : Stocks Struggle After New Records	DJ
29/02	An unknown buyer agreed to acquire 39.3% stake in Exicure, Inc. from DGP Co.,Ltd. for KRW 6 billion.	CI

Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis	06/02
Wall Street Set to Open Lower Friday; Employment Growth Tops Forecasts	08/12
Investors Look Ahead to Economic Indicators as US Futures Trend Lower in Friday's Premarket	08/12
Top Premarket Gainers	08/12
Northwestern University Notifies Exicure, Inc. that it Was Terminating the 2014 License	07/23/07
Exicure, Inc. Appoints Minhee Eom to the Board	28/23/28
Exicure Appoints New CEO, CFO	23/23/23
Exicure, Inc. Announces Executive Changes	23/23/23
Exicure, Inc. Announces Executive Changes	23/23/23
Exicure Inc Provides Information to Shareholders	23/23/23
Exicure, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	12/23/12
CBI Co Provides Information to Shareholders of Exicure Inc	08/23/08
Exicure, Inc. Announces Resignation of Cheolho Jo from the Board and the Audit Committee	05/23/05
Exicure, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15
Exicure, Inc. Appoints Jung Sang Kim as Chief Executive Officer	29/23/29
Exicure, Inc. Appoints Jung Sang Kim as Class II Director	29/23/29
Exicure Says Board Fully Backs CEO in Exploration of Strategic Alternatives	27/23/27
CBI USA Inc Sends a Letter to Exicure Inc	17/23/17
Exicure, Inc. Announces Board Changes	28/23/28
Exicure, Inc. Announces CEO Changes	28/23/28

No results for this search